High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome (Haematologica (2008) 93, (1894-1898) DOI 10.3324/haematol.13112)

M. E. D. Chamuleau, A. A. van de Loosdrecht, C. J. Hess, J. J. W. M. Janssen, A. Zevenbergen, R. Delwel, P. J. M. Valk, B. Löwenberg, G. J. Ossenkoppele

Research output: Contribution to journalErratum/CorrigendumAcademicpeer-review

Original languageEnglish
Pages (from-to)1182
Issue number8
Publication statusPublished - 2009

Cite this